SEC Form 4 · accession 0001702626-17-000003
AIM ImmunoTech Inc. · AIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stewart Appelrouth
Director
Period of report
Apr 30, 2017
Accepted (ET)
Jun 26, 2017 · 11:09 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000946644
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to buy Common StockF1 | $0.67 | Apr 30, 2017 | A | 12,644 | A | Apr 30, 2017 | Apr 30, 2027 | Common Stock | 12,644 | 12,644 | D |
| Options to buy Common StockF1 | $0.64 | May 15, 2017 | A | 13,238 | A | May 15, 2017 | May 15, 2027 | Common Stock | 13,238 | 13,238 | D |
| Options to buy Common StockF1 | $0.59 | May 31, 2017 | A | 14,361 | A | May 31, 2017 | May 31, 2027 | Common Stock | 14,361 | 14,361 | D |
| Options to buy Common StockF1 | $0.49 | Jun 15, 2017 | A | 17,287 | A | Jun 15, 2017 | Jun 15, 2027 | Common Stock | 17,287 | 17,287 | D |
Explanation of responses
- F1This option is being issued in exchange for a voluntary 100% reduction in salary.